<DOC>
	<DOCNO>NCT02179619</DOCNO>
	<brief_summary>The study verify Dermalax ( Deep ) inferior reference device , RestylaneÂ® , term efficacy safety correction nasolabial fold . Subjects voluntarily sign informed consent judge eligible study intradermally inject study device comparator device . Subjects randomize receive injection study device comparator device nasolabial fold . Efficacy evaluate base change Wrinkle Severity Rating Scale ( WSRS ) baseline . Safety assess base 24 week follow visit subject diary give subject first 2 week injection . Any uncomfortable thing adverse event investigate subject diary follow visit .</brief_summary>
	<brief_title>Clinical Study Evaluate Efficacy Safety Dermalax ( Deep ) Correction Nasolabial Folds</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>1 . Male female subject younger 30 65 year age . 2 . Subjects score 3 4 Wrinkle Severity Rating Scale ( WSRS ) want improve appearance nasolabial fold ( subject need score side . * ) *The score need side , two nasolabial fold symmetry range 34 . 3 . Subjects symmetric nasolabial fold . 4 . Subjects agree discontinue use dermatological procedure therapy , include facial wrinkle reduction procedure . 5 . Subjects ability understand follow instruction commit availability entire study period . 6 . Subjects voluntarily decide participate study sign informed consent form . 1 . Subjects show hypersensitive skin reaction investigational device , confirm intradermal reaction test perform screen . 2 . Subjects receive antithrombotic agent within 2 week prior screen ( exception low dose Aspirin 100 mg , maximum 300 mg/day ) NSAIDs Vitamin E within 1 week . 3 . Subjects liver problem and/or blood coagulation defect subject require administration antithrombotic agent clinical trial period ( exception low dose Aspirin 100 mg , maximum 300 mg/day ) . 4 . Subjects use local ointment face ( medication steroid retinoid include cosmetic product exclude criterion ) within 4 week prior screen subject plan use ointment clinical trial period . 5 . Subjects receive treatment wrinkle acne within 24 week prior screen . 6 . Subjects receive facial ( chemical ) peel and/or skin rejuvenation procedure plastic surgery , include injection Botulinum toxin , within 24 week prior screen . 7 . Subjects permanent skin expander soft form silicon implant face . 8 . Subjects scars face require medical treatment receive treatment year subject scars wound test investigational device apply . 9 . Subjects skin disease wound infection face .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>